HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access

Seeking to quickly widen global access to Covid-19 vaccines, academics, and patient advocates are urging the Biden administration to use a key patent owned by the U.S. government to boost manufacturing and distribution of the Moderna (MRNA) shot.